Global Structural Heart Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis and Forecast 2020 to 2027

1. Preface
1.1. Definition and Scope
1.2. Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Research Methodology
3. Executive Summary
4. Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Surge in awareness about structural heart diseases
4.3.1.2. Rise in prevalence of structural heart diseases
4.3.1.3. Increase in demand for minimally invasive procedures
4.3.1.4. Technological advancements in structural heart devices
4.3.1.5. Favorable reimbursement policies
4.3.1.6. Longer life expectancy along with increase in geriatric population
4.3.2. Restraints
4.3.2.1. Stringent government approval process
4.3.2.2. High cost of minimally invasive procedures
4.3.3. Opportunities
4.3.3.1. Lucrative opportunities in emerging markets
4.3.3.2. Increase in demand for heart valve repair procedures
4.4. Global Market Analysis and Forecast, 2016–2026
5. Market Outlook
5.1. Product Mapping
5.2. Trials Mapping
5.3. Price Comparison Analysis
5.4. Technological Advancements
5.5. Key Industry Events
6. Global Structural Heart Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Biological/Tissue Valves
6.3.1.1. Transcatheter Heart Valves
6.3.1.2. Surgical Heart Valve
6.3.2. Mechanical Heart Valves
6.3.3. Annuloplasty Rings
6.3.4. Occluders
6.3.5. Accessories
6.4. Market Attractiveness, by Product
7. Global Structural Heart Devices Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Procedure, 2016–2026
7.3.1. Replacement Procedure
7.3.2. Repair Procedure
7.4. Market Attractiveness, by Procedure
8. Global Structural Heart Devices Market Analysis and Forecasts, by Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Indication, 2016–2026
8.3.1. Valve Stenosis
8.3.2. Valve Regurgitation
8.3.3. Cardiomyopathy
8.3.4. Congenital Heart Defects
8.3.5. Others
8.4. Market Attractiveness, by Indication
9. Global Structural Heart Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Structural Heart Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Biological/Tissue Valves
10.2.1.1. Transcatheter Heart Valves
10.2.1.2. Surgical Heart Valve
10.2.2. Mechanical Heart Valves
10.2.3. Annuloplasty Rings
10.2.4. Occluders
10.2.5. Accessories
10.3. Market Value Forecast, by Procedure, 2016–2026
10.3.1. Replacement Procedure
10.3.2. Repair Procedure
10.4. Market Value Forecast, by Indication, 2016–2026
10.4.1. Valve Stenosis
10.4.2. Valve Regurgitation
10.4.3. Cardiomyopathy
10.4.4. Congenital Heart Defects
10.4.5. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Procedure
10.6.3. By Indication
10.6.4. By Country
11. Europe Structural Heart Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2016–2026
11.2.1. Biological/Tissue Valves
11.2.1.1. Transcatheter Heart Valves
11.2.1.2. Surgical Heart Valve
11.2.2. Mechanical Heart Valves
11.2.3. Annuloplasty Rings
11.2.4. Occluders
11.2.5. Accessories
11.3. Market Value Forecast, by Procedure, 2016–2026
11.3.1. Replacement Procedure
11.3.2. Repair Procedure
11.4. Market Value Forecast, by Indication, 2016–2026
11.4.1. Valve Stenosis
11.4.2. Valve Regurgitation
11.4.3. Cardiomyopathy
11.4.4. Congenital Heart Defects
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Procedure
11.6.3. By Indication
11.6.4. By Country/Sub-region
12. Asia Pacific Structural Heart Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2016–2026
12.2.1. Biological/ Tissue Valves
12.2.1.1. Transcatheter Heart Valves
12.2.1.2. Surgical Heart Valve
12.2.2. Mechanical Heart Valves
12.2.3. Annuloplasty Rings
12.2.4. Occluders
12.2.5. Accessories
12.3. Market Value Forecast, by Procedure, 2016–2026
12.3.1. Replacement Procedure
12.3.2. Repair Procedure
12.4. Market Value Forecast, by Indication, 2016–2026
12.4.1. Valve Stenosis
12.4.2. Valve Regurgitation
12.4.3. Cardiomyopathy
12.4.4. Congenital Heart Defects
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Procedure
12.6.3. By Indication
12.6.4. By Country/Sub-region
13. Latin America Structural Heart Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2016–2026
13.2.1. Biological/ Tissue Valves
13.2.1.1. Transcatheter Heart Valves
13.2.1.2. Surgical Heart Valve
13.2.2. Mechanical Heart Valves
13.2.3. Annuloplasty Rings
13.2.4. Occluders
13.2.5. Accessories
13.3. Market Value Forecast, by Procedure, 2016–2026
13.3.1. Replacement Procedure
13.3.2. Repair Procedure
13.4. Market Value Forecast, by Indication, 2016–2026
13.4.1. Valve Stenosis
13.4.2. Valve Regurgitation
13.4.3. Cardiomyopathy
13.4.4. Congenital Heart Defects
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Procedure
13.6.3. By Indication
13.6.4. By Country/Sub-region
14. Middle East & Africa Structural Heart Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2016–2026
14.2.1. Biological/ Tissue Valves
14.2.1.1. Transcatheter Heart Valves
14.2.1.2. Surgical Heart Valve
14.2.2. Mechanical Heart Valves
14.2.3. Annuloplasty Rings
14.2.4. Occluders
14.2.5. Accessories
14.3. Market Value Forecast, by Procedure, 2016–2026
14.3.1. Replacement Procedure
14.3.2. Repair Procedure
14.4. Market Value Forecast, by Indication, 2016–2026
14.4.1. Valve Stenosis
14.4.2. Valve Regurgitation
14.4.3. Cardiomyopathy
14.4.4. Congenital Heart Defects
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Procedure
14.6.3. By Indication
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. CryoLife, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Abbott
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Boston Scientific Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Edwards Lifesciences Corporation
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. LivaNova PLC
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Lepu Medical
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Micro Interventional Devices, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Lifetech Scientific
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview